Long‐Term Observation of Cyclosporine as Second‐Line Therapy in Adults for Severe Acute Autoimmune Hepatitis
Gespeichert in:
| Veröffentlicht in: | Hepatology (Baltimore, Md.) Md.), 2021-06, Vol.73 (6), p.2594-2597 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2597 |
|---|---|
| container_issue | 6 |
| container_start_page | 2594 |
| container_title | Hepatology (Baltimore, Md.) |
| container_volume | 73 |
| creator | Noguchi, Fumie Chu, Po‐sung Taniki, Nobuhito Yoshida, Aya Morikawa, Rei Yamaguchi, Akihiro Ikura, Akihiko Yamataka, Karin Hoshi, Hitomi Usui, Shingo Ebinuma, Hirotoshi Saito, Hidetsugu Kanai, Takanori Nakamoto, Nobuhiro |
| description | |
| doi_str_mv | 10.1002/hep.31597 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_webof</sourceid><recordid>TN_cdi_webofscience_primary_000652533800001CitationCount</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2542545582</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4197-2dfcc64e95259d5def298f2b5e8de8badf40bd178497ff50ee15ccf8ec9080253</originalsourceid><addsrcrecordid>eNqN0d2K1DAUB_AgijuuXvgCUvBGke7mo2mTy6GsjjCwguN1aZMTN0ub1KRZmTsfwWf0SczsjHshCEJIQvjlcJI_Qi8JviAY08sbmC8Y4bJ5hFaE06ZkjOPHaIVpg0tJmDxDz2K8xRjLioqn6IwxXAsq6xWat959_fXj5w7CVFwPEcJdv1jvCm-Kdq9GH2cfrIOij8VnUN7pjLeHg90NhH7eF9YVa53GJRbGh2zuIECxVmnJc1q8naaU9QbmXHex8Tl6YvoxwovTeo6-vL_atZtye_3hY7velqoisimpNkrVFUhOudRcg6FSGDpwEBrE0GtT4UGTRlSyMYZjAMKVMgKUxAJTzs7Rm2PdOfhvCeLSTTYqGMfegU-xoxUnoqYNP9DXf9Fbn4LL3XWUV3lwLmhWb49KBR9jANPNwU592HcEd4cYuhxDdx9Dtq9OFdMwgX6Qf_49A3EE32HwJioLTsEDy0HV-d2MibzDpLXLfSatT27JV9_9_9WsL0_ajrD_d8vd5urTsfffoOy0ww</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2542545582</pqid></control><display><type>article</type><title>Long‐Term Observation of Cyclosporine as Second‐Line Therapy in Adults for Severe Acute Autoimmune Hepatitis</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Noguchi, Fumie ; Chu, Po‐sung ; Taniki, Nobuhito ; Yoshida, Aya ; Morikawa, Rei ; Yamaguchi, Akihiro ; Ikura, Akihiko ; Yamataka, Karin ; Hoshi, Hitomi ; Usui, Shingo ; Ebinuma, Hirotoshi ; Saito, Hidetsugu ; Kanai, Takanori ; Nakamoto, Nobuhiro</creator><creatorcontrib>Noguchi, Fumie ; Chu, Po‐sung ; Taniki, Nobuhito ; Yoshida, Aya ; Morikawa, Rei ; Yamaguchi, Akihiro ; Ikura, Akihiko ; Yamataka, Karin ; Hoshi, Hitomi ; Usui, Shingo ; Ebinuma, Hirotoshi ; Saito, Hidetsugu ; Kanai, Takanori ; Nakamoto, Nobuhiro</creatorcontrib><identifier>ISSN: 0270-9139</identifier><identifier>EISSN: 1527-3350</identifier><identifier>DOI: 10.1002/hep.31597</identifier><identifier>PMID: 33068296</identifier><language>eng</language><publisher>PHILADELPHIA: Lippincott Williams & Wilkins</publisher><subject><![CDATA[Acute Disease ; Administration, Intravenous ; Adult ; Calcineurin Inhibitors - administration & dosage ; Calcineurin Inhibitors - adverse effects ; Cyclosporine - administration & dosage ; Cyclosporine - adverse effects ; Cyclosporins ; Drug Monitoring - methods ; Female ; Gastroenterology & Hepatology ; Hepatitis ; Hepatitis, Autoimmune - diagnosis ; Hepatitis, Autoimmune - drug therapy ; Hepatitis, Autoimmune - physiopathology ; Hepatology ; Humans ; Immunosuppressive Agents - administration & dosage ; Immunosuppressive Agents - adverse effects ; Life Sciences & Biomedicine ; Liver Function Tests - methods ; Long-Term Care - methods ; Long-Term Care - statistics & numerical data ; Male ; Retrospective Studies ; Science & Technology ; Severity of Illness Index ; Time ; Treatment Outcome]]></subject><ispartof>Hepatology (Baltimore, Md.), 2021-06, Vol.73 (6), p.2594-2597</ispartof><rights>2020 by the American Association for the Study of Liver Diseases.</rights><rights>2021 by the American Association for the Study of Liver Diseases.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>5</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000652533800001</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c4197-2dfcc64e95259d5def298f2b5e8de8badf40bd178497ff50ee15ccf8ec9080253</citedby><cites>FETCH-LOGICAL-c4197-2dfcc64e95259d5def298f2b5e8de8badf40bd178497ff50ee15ccf8ec9080253</cites><orcidid>0000-0002-8687-2760 ; 0000-0003-3627-5412</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhep.31597$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhep.31597$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27929,27930,39263,45579,45580</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33068296$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Noguchi, Fumie</creatorcontrib><creatorcontrib>Chu, Po‐sung</creatorcontrib><creatorcontrib>Taniki, Nobuhito</creatorcontrib><creatorcontrib>Yoshida, Aya</creatorcontrib><creatorcontrib>Morikawa, Rei</creatorcontrib><creatorcontrib>Yamaguchi, Akihiro</creatorcontrib><creatorcontrib>Ikura, Akihiko</creatorcontrib><creatorcontrib>Yamataka, Karin</creatorcontrib><creatorcontrib>Hoshi, Hitomi</creatorcontrib><creatorcontrib>Usui, Shingo</creatorcontrib><creatorcontrib>Ebinuma, Hirotoshi</creatorcontrib><creatorcontrib>Saito, Hidetsugu</creatorcontrib><creatorcontrib>Kanai, Takanori</creatorcontrib><creatorcontrib>Nakamoto, Nobuhiro</creatorcontrib><title>Long‐Term Observation of Cyclosporine as Second‐Line Therapy in Adults for Severe Acute Autoimmune Hepatitis</title><title>Hepatology (Baltimore, Md.)</title><addtitle>HEPATOLOGY</addtitle><addtitle>Hepatology</addtitle><subject>Acute Disease</subject><subject>Administration, Intravenous</subject><subject>Adult</subject><subject>Calcineurin Inhibitors - administration & dosage</subject><subject>Calcineurin Inhibitors - adverse effects</subject><subject>Cyclosporine - administration & dosage</subject><subject>Cyclosporine - adverse effects</subject><subject>Cyclosporins</subject><subject>Drug Monitoring - methods</subject><subject>Female</subject><subject>Gastroenterology & Hepatology</subject><subject>Hepatitis</subject><subject>Hepatitis, Autoimmune - diagnosis</subject><subject>Hepatitis, Autoimmune - drug therapy</subject><subject>Hepatitis, Autoimmune - physiopathology</subject><subject>Hepatology</subject><subject>Humans</subject><subject>Immunosuppressive Agents - administration & dosage</subject><subject>Immunosuppressive Agents - adverse effects</subject><subject>Life Sciences & Biomedicine</subject><subject>Liver Function Tests - methods</subject><subject>Long-Term Care - methods</subject><subject>Long-Term Care - statistics & numerical data</subject><subject>Male</subject><subject>Retrospective Studies</subject><subject>Science & Technology</subject><subject>Severity of Illness Index</subject><subject>Time</subject><subject>Treatment Outcome</subject><issn>0270-9139</issn><issn>1527-3350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>HGBXW</sourceid><sourceid>EIF</sourceid><recordid>eNqN0d2K1DAUB_AgijuuXvgCUvBGke7mo2mTy6GsjjCwguN1aZMTN0ub1KRZmTsfwWf0SczsjHshCEJIQvjlcJI_Qi8JviAY08sbmC8Y4bJ5hFaE06ZkjOPHaIVpg0tJmDxDz2K8xRjLioqn6IwxXAsq6xWat959_fXj5w7CVFwPEcJdv1jvCm-Kdq9GH2cfrIOij8VnUN7pjLeHg90NhH7eF9YVa53GJRbGh2zuIECxVmnJc1q8naaU9QbmXHex8Tl6YvoxwovTeo6-vL_atZtye_3hY7velqoisimpNkrVFUhOudRcg6FSGDpwEBrE0GtT4UGTRlSyMYZjAMKVMgKUxAJTzs7Rm2PdOfhvCeLSTTYqGMfegU-xoxUnoqYNP9DXf9Fbn4LL3XWUV3lwLmhWb49KBR9jANPNwU592HcEd4cYuhxDdx9Dtq9OFdMwgX6Qf_49A3EE32HwJioLTsEDy0HV-d2MibzDpLXLfSatT27JV9_9_9WsL0_ajrD_d8vd5urTsfffoOy0ww</recordid><startdate>202106</startdate><enddate>202106</enddate><creator>Noguchi, Fumie</creator><creator>Chu, Po‐sung</creator><creator>Taniki, Nobuhito</creator><creator>Yoshida, Aya</creator><creator>Morikawa, Rei</creator><creator>Yamaguchi, Akihiro</creator><creator>Ikura, Akihiko</creator><creator>Yamataka, Karin</creator><creator>Hoshi, Hitomi</creator><creator>Usui, Shingo</creator><creator>Ebinuma, Hirotoshi</creator><creator>Saito, Hidetsugu</creator><creator>Kanai, Takanori</creator><creator>Nakamoto, Nobuhiro</creator><general>Lippincott Williams & Wilkins</general><general>Wiley Subscription Services, Inc</general><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8687-2760</orcidid><orcidid>https://orcid.org/0000-0003-3627-5412</orcidid></search><sort><creationdate>202106</creationdate><title>Long‐Term Observation of Cyclosporine as Second‐Line Therapy in Adults for Severe Acute Autoimmune Hepatitis</title><author>Noguchi, Fumie ; Chu, Po‐sung ; Taniki, Nobuhito ; Yoshida, Aya ; Morikawa, Rei ; Yamaguchi, Akihiro ; Ikura, Akihiko ; Yamataka, Karin ; Hoshi, Hitomi ; Usui, Shingo ; Ebinuma, Hirotoshi ; Saito, Hidetsugu ; Kanai, Takanori ; Nakamoto, Nobuhiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4197-2dfcc64e95259d5def298f2b5e8de8badf40bd178497ff50ee15ccf8ec9080253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acute Disease</topic><topic>Administration, Intravenous</topic><topic>Adult</topic><topic>Calcineurin Inhibitors - administration & dosage</topic><topic>Calcineurin Inhibitors - adverse effects</topic><topic>Cyclosporine - administration & dosage</topic><topic>Cyclosporine - adverse effects</topic><topic>Cyclosporins</topic><topic>Drug Monitoring - methods</topic><topic>Female</topic><topic>Gastroenterology & Hepatology</topic><topic>Hepatitis</topic><topic>Hepatitis, Autoimmune - diagnosis</topic><topic>Hepatitis, Autoimmune - drug therapy</topic><topic>Hepatitis, Autoimmune - physiopathology</topic><topic>Hepatology</topic><topic>Humans</topic><topic>Immunosuppressive Agents - administration & dosage</topic><topic>Immunosuppressive Agents - adverse effects</topic><topic>Life Sciences & Biomedicine</topic><topic>Liver Function Tests - methods</topic><topic>Long-Term Care - methods</topic><topic>Long-Term Care - statistics & numerical data</topic><topic>Male</topic><topic>Retrospective Studies</topic><topic>Science & Technology</topic><topic>Severity of Illness Index</topic><topic>Time</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Noguchi, Fumie</creatorcontrib><creatorcontrib>Chu, Po‐sung</creatorcontrib><creatorcontrib>Taniki, Nobuhito</creatorcontrib><creatorcontrib>Yoshida, Aya</creatorcontrib><creatorcontrib>Morikawa, Rei</creatorcontrib><creatorcontrib>Yamaguchi, Akihiro</creatorcontrib><creatorcontrib>Ikura, Akihiko</creatorcontrib><creatorcontrib>Yamataka, Karin</creatorcontrib><creatorcontrib>Hoshi, Hitomi</creatorcontrib><creatorcontrib>Usui, Shingo</creatorcontrib><creatorcontrib>Ebinuma, Hirotoshi</creatorcontrib><creatorcontrib>Saito, Hidetsugu</creatorcontrib><creatorcontrib>Kanai, Takanori</creatorcontrib><creatorcontrib>Nakamoto, Nobuhiro</creatorcontrib><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Hepatology (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Noguchi, Fumie</au><au>Chu, Po‐sung</au><au>Taniki, Nobuhito</au><au>Yoshida, Aya</au><au>Morikawa, Rei</au><au>Yamaguchi, Akihiro</au><au>Ikura, Akihiko</au><au>Yamataka, Karin</au><au>Hoshi, Hitomi</au><au>Usui, Shingo</au><au>Ebinuma, Hirotoshi</au><au>Saito, Hidetsugu</au><au>Kanai, Takanori</au><au>Nakamoto, Nobuhiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long‐Term Observation of Cyclosporine as Second‐Line Therapy in Adults for Severe Acute Autoimmune Hepatitis</atitle><jtitle>Hepatology (Baltimore, Md.)</jtitle><stitle>HEPATOLOGY</stitle><addtitle>Hepatology</addtitle><date>2021-06</date><risdate>2021</risdate><volume>73</volume><issue>6</issue><spage>2594</spage><epage>2597</epage><pages>2594-2597</pages><issn>0270-9139</issn><eissn>1527-3350</eissn><cop>PHILADELPHIA</cop><pub>Lippincott Williams & Wilkins</pub><pmid>33068296</pmid><doi>10.1002/hep.31597</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-8687-2760</orcidid><orcidid>https://orcid.org/0000-0003-3627-5412</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0270-9139 |
| ispartof | Hepatology (Baltimore, Md.), 2021-06, Vol.73 (6), p.2594-2597 |
| issn | 0270-9139 1527-3350 |
| language | eng |
| recordid | cdi_webofscience_primary_000652533800001CitationCount |
| source | MEDLINE; Access via Wiley Online Library; Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; EZB-FREE-00999 freely available EZB journals |
| subjects | Acute Disease Administration, Intravenous Adult Calcineurin Inhibitors - administration & dosage Calcineurin Inhibitors - adverse effects Cyclosporine - administration & dosage Cyclosporine - adverse effects Cyclosporins Drug Monitoring - methods Female Gastroenterology & Hepatology Hepatitis Hepatitis, Autoimmune - diagnosis Hepatitis, Autoimmune - drug therapy Hepatitis, Autoimmune - physiopathology Hepatology Humans Immunosuppressive Agents - administration & dosage Immunosuppressive Agents - adverse effects Life Sciences & Biomedicine Liver Function Tests - methods Long-Term Care - methods Long-Term Care - statistics & numerical data Male Retrospective Studies Science & Technology Severity of Illness Index Time Treatment Outcome |
| title | Long‐Term Observation of Cyclosporine as Second‐Line Therapy in Adults for Severe Acute Autoimmune Hepatitis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T20%3A56%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_webof&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long%E2%80%90Term%20Observation%20of%20Cyclosporine%20as%20Second%E2%80%90Line%20Therapy%20in%20Adults%20for%20Severe%20Acute%20Autoimmune%20Hepatitis&rft.jtitle=Hepatology%20(Baltimore,%20Md.)&rft.au=Noguchi,%20Fumie&rft.date=2021-06&rft.volume=73&rft.issue=6&rft.spage=2594&rft.epage=2597&rft.pages=2594-2597&rft.issn=0270-9139&rft.eissn=1527-3350&rft_id=info:doi/10.1002/hep.31597&rft_dat=%3Cproquest_webof%3E2542545582%3C/proquest_webof%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2542545582&rft_id=info:pmid/33068296&rfr_iscdi=true |